Laurus Labs Balance Sheet Health
Financial Health criteria checks 4/6
Laurus Labs has a total shareholder equity of ₹41.2B and total debt of ₹25.1B, which brings its debt-to-equity ratio to 60.9%. Its total assets and total liabilities are ₹83.9B and ₹42.7B respectively. Laurus Labs's EBIT is ₹4.2B making its interest coverage ratio 2.3. It has cash and short-term investments of ₹1.4B.
Key information
60.9%
Debt to equity ratio
₹25.07b
Debt
| Interest coverage ratio | 2.3x |
| Cash | ₹1.42b |
| Equity | ₹41.16b |
| Total liabilities | ₹42.71b |
| Total assets | ₹83.87b |
Recent financial health updates
Is Laurus Labs (NSE:LAURUSLABS) A Risky Investment?
Dec 01
These 4 Measures Indicate That Laurus Labs (NSE:LAURUSLABS) Is Using Debt Reasonably Well
Jul 06Is Laurus Labs (NSE:LAURUSLABS) A Risky Investment?
Dec 18Is Laurus Labs (NSE:LAURUSLABS) Using Too Much Debt?
Sep 09Laurus Labs (NSE:LAURUSLABS) Has A Somewhat Strained Balance Sheet
Jun 11Laurus Labs (NSE:LAURUSLABS) Seems To Use Debt Quite Sensibly
Feb 26Recent updates
Laurus Labs' (NSE:LAURUSLABS) Dividend Will Be ₹0.40
Apr 28Laurus Labs Limited Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Jan 27Is Laurus Labs (NSE:LAURUSLABS) A Risky Investment?
Dec 01Laurus Labs (NSE:LAURUSLABS) Is Paying Out Less In Dividends Than Last Year
Oct 22These 4 Measures Indicate That Laurus Labs (NSE:LAURUSLABS) Is Using Debt Reasonably Well
Jul 06Laurus Labs (NSE:LAURUSLABS) Is Paying Out A Dividend Of ₹1.20
Apr 30Is Laurus Labs (NSE:LAURUSLABS) A Risky Investment?
Dec 18Is Laurus Labs Limited (NSE:LAURUSLABS) Expensive For A Reason? A Look At Its Intrinsic Value
Sep 27Is Laurus Labs (NSE:LAURUSLABS) Using Too Much Debt?
Sep 09Laurus Labs (NSE:LAURUSLABS) Has A Somewhat Strained Balance Sheet
Jun 11Laurus Labs (NSE:LAURUSLABS) Is Paying Out A Larger Dividend Than Last Year
May 02Laurus Labs (NSE:LAURUSLABS) Seems To Use Debt Quite Sensibly
Feb 26With EPS Growth And More, Laurus Labs (NSE:LAURUSLABS) Is Interesting
Feb 11Does Laurus Labs (NSE:LAURUSLABS) Have A Healthy Balance Sheet?
Nov 26Laurus Labs (NSE:LAURUSLABS) Is Due To Pay A Dividend Of ₹0.80
Nov 13I Ran A Stock Scan For Earnings Growth And Laurus Labs (NSE:LAURUSLABS) Passed With Ease
Nov 12Laurus Labs (NSE:LAURUSLABS) Has Affirmed Its Dividend Of ₹0.80
Oct 30A Look At The Intrinsic Value Of Laurus Labs Limited (NSE:LAURUSLABS)
Oct 05Should You Be Adding Laurus Labs (NSE:LAURUSLABS) To Your Watchlist Today?
Aug 10Laurus Labs (NSE:LAURUSLABS) Seems To Use Debt Quite Sensibly
Jul 23Is Laurus Labs Limited (NSE:LAURUSLABS) Worth ₹547 Based On Its Intrinsic Value?
Jun 06We Think That There Are Issues Underlying Laurus Labs' (NSE:LAURUSLABS) Earnings
May 06Should You Be Adding Laurus Labs (NSE:LAURUSLABS) To Your Watchlist Today?
May 05We Think Laurus Labs (NSE:LAURUSLABS) Can Stay On Top Of Its Debt
Mar 16Could The Laurus Labs Limited (NSE:LAURUSLABS) Ownership Structure Tell Us Something Useful?
Mar 01Shareholders Are Raving About How The Laurus Labs (NSE:LAURUSLABS) Share Price Increased 331%
Feb 16There's A Lot To Like About Laurus Labs' (NSE:LAURUSLABS) Upcoming ₹0.40 Dividend
Feb 03
Laurus Labs Limited Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next
Jan 30Financial Position Analysis
Short Term Liabilities: LAURUSLABS's short term assets (₹38.3B) exceed its short term liabilities (₹31.1B).
Long Term Liabilities: LAURUSLABS's short term assets (₹38.3B) exceed its long term liabilities (₹11.6B).
Debt to Equity History and Analysis
Debt Level: LAURUSLABS's net debt to equity ratio (57.5%) is considered high.
Reducing Debt: LAURUSLABS's debt to equity ratio has reduced from 66.5% to 60.9% over the past 5 years.
Debt Coverage: LAURUSLABS's debt is well covered by operating cash flow (26.6%).
Interest Coverage: LAURUSLABS's interest payments on its debt are not well covered by EBIT (2.3x coverage).